Enlivex Therapeutics Ltd (ENLV)
0.9300 x 30 0.9500 x 1
Post-market by (Cboe BZX)
0.9500 -0.0200 (-2.06%) 04/01/25 [NASDAQ]
0.9300 x 30 0.9500 x 1
Post-market 0.9300 -0.0200 (-2.11%) 19:37 ET
for Tue, Apr 1st, 2025
Results
download Want to compare other data? Select FieldsSymbol | ENLV | ZTS | TAK | SMMT | UTHR |
Company | Enlivex Therapeutics Ltd | Zoetis Inc Cl A | Takeda Pharmaceutical Ltd ADR | Summit Therapeu ADR | United Therapeutic |
Price Information | |||||
Exchange | NASDAQ | NYSE | NYSE | NASDAQ | NASDAQ |
Open | 0.9873 | 163.92 | 15.00 | 19.19 | 308.17 |
High | 1.0300 | 165.72 | 15.02 | 19.90 | 311.55 |
Low | 0.9200 | 161.39 | 14.88 | 18.61 | 303.33 |
Last | 0.9500 | 161.91 | 14.90 | 18.80 | 306.88 |
Change | -0.0202 | -2.74 | +0.03 | -0.49 | -1.39 |
% Change | -2.08% | -1.66% | +0.20% | -2.54% | -0.45% |
Volume | 88,200 | 2,734,964 | 1,374,960 | 2,785,700 | 576,600 |
20-Day Average Volume | 147,160 | 2,475,725 | 1,537,460 | 2,319,895 | 494,955 |
Previous Close | 0.9702 | 164.65 | 14.87 | 19.29 | 308.27 |
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs | Medical - Drugs |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 1.0978 | 164.27 | 15.05 | 19.59 | 311.83 |
20-Day Raw Stochastic | 8.11% | 19.30% | 27.03% | 43.69% | 31.88% |
20-Day Relative Strength | 41.20% | 45.58% | 57.93% | 46.34% | 39.66% |
Weighted Alpha | -53.29 | -6.12 | +12.07 | -6.25 | +13.92 |
Today's Opinion | 88% Sell | 100% Sell | 72% Buy | Hold | 88% Sell |
Previous Opinion | 88% Sell | 100% Sell | 72% Buy | Hold | 88% Sell |
Last Month's Opinion | 96% Sell | 48% Sell | 40% Buy | 48% Buy | 40% Sell |
Performance | |||||
5-Days | |||||
%Chg | -12.84% since 03/25/25 | +0.38% since 03/25/25 | -0.93% since 03/25/25 | -7.11% since 03/25/25 | -3.11% since 03/25/25 |
Low | 0.9200 on 04/01/25 | 160.68 on 03/26/25 | 14.75 on 03/31/25 | 18.61 on 04/01/25 | 298.60 on 03/31/25 |
High | 1.1100 on 03/26/25 | 165.72 on 04/01/25 | 15.17 on 03/27/25 | 21.70 on 03/26/25 | 318.40 on 03/27/25 |
1-Month | |||||
%Chg | -20.83% since 02/28/25 | -3.19% since 02/28/25 | +3.40% since 02/28/25 | -9.13% since 02/28/25 | -4.11% since 02/28/25 |
Low | 0.9200 on 04/01/25 | 158.30 on 03/14/25 | 14.55 on 03/03/25 | 16.55 on 03/10/25 | 298.60 on 03/31/25 |
High | 1.2900 on 03/14/25 | 177.00 on 03/10/25 | 15.31 on 03/21/25 | 21.70 on 03/26/25 | 324.57 on 03/18/25 |
3-Month | |||||
%Chg | -18.80% since 12/31/24 | -0.63% since 12/31/24 | +12.54% since 12/31/24 | +5.35% since 12/31/24 | -13.03% since 12/31/24 |
Low | 0.9200 on 04/01/25 | 154.32 on 02/18/25 | 12.80 on 01/23/25 | 16.46 on 01/14/25 | 298.60 on 03/31/25 |
High | 1.2900 on 03/14/25 | 177.40 on 02/06/25 | 15.31 on 03/21/25 | 25.00 on 01/24/25 | 383.51 on 02/19/25 |
6-Month | |||||
%Chg | -40.99% since 10/01/24 | -16.72% since 10/01/24 | +4.34% since 10/01/24 | -6.47% since 10/01/24 | -14.24% since 10/01/24 |
Low | 0.8101 on 11/21/24 | 154.32 on 02/18/25 | 12.80 on 01/23/25 | 16.46 on 01/14/25 | 298.60 on 03/31/25 |
High | 1.7497 on 10/16/24 | 196.55 on 10/17/24 | 15.31 on 03/21/25 | 25.00 on 01/24/25 | 417.82 on 11/08/24 |
Key Statistics | |||||
Market Capitalization, $K | 20,768 | 73,728,952 | 47,314,836 | 14,229,848 | 13,845,019 |
Shares Outstanding, K | 21,406 | 447,792 | 3,181,899 | 737,680 | 44,912 |
Annual Sales | 0 | 9,256,000,000 | 29,419,960,000 | 0 | 2,877,400,000 |
Annual Net Income | -29,070,000 | 2,486,000,000 | 994,060,000 | -221,320,000 | 1,195,100,000 |
Last Quarter Sales | 0 | 2,317,000,000 | 7,511,170,000 | 0 | 735,900,000 |
Last Quarter Net Income | -2,600,000 | 581,000,000 | 156,180,000 | -61,200,000 | 301,300,000 |
60-Month Beta | 1.10 | 0.94 | 0.46 | -1.03 | 0.64 |
Per-Share Information | |||||
Most Recent Earnings | -0.12 on 11/29/24 | 1.40 on 02/13/25 | 0.42 on 01/30/25 | -0.08 on 02/24/25 | 6.19 on 02/26/25 |
Latest Earnings Date | 04/04/25 | 05/06/25 | 05/08/25 | 05/07/25 | 05/07/25 |
Most Recent Dividend | N/A | 0.500 on 01/21/25 | 0.267 on 09/30/24 | N/A | N/A |
Next Ex-Dividends Date | N/A | 04/21/25 | 09/30/24 | N/A | N/A |
Ratios | |||||
Price/Earnings ttm | 0.00 | 27.55 | 10.60 | 0.00 | 12.48 |